Faster recovery after ERCP? new trial tests two reversal drugs
NCT ID NCT06136585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares sugammadex and neostigmine to reverse muscle paralysis caused by rocuronium during ERCP, a procedure to treat bile duct issues. About 80 adults will be randomly assigned to one of the two drugs. The goal is to see which drug helps patients recover faster and causes fewer side effects like nausea.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sugammadex and neostigmine
- What this could lead to
- If sugammadex works better, patients could recover faster and feel less sick after ERCP procedures.
- What could go wrong
- This is a small, early-phase trial focused on recovery time, not a cure. Results may not apply to all patients or procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROMUSCULAR BLOCKS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic Fairview Hospital
RECRUITINGCleveland, Ohio, 44111, United States